Salmonella
Salmonella
BACTERIOLOGY
• Salmonella serotypes host range: some are highly adapted to particular mammals
or amphibians, and others infect a broad range of hosts.
• Strictly adapted to humans: Salmonella enterica serovar Typhi
• Those that infect humans and other animals: S enterica serovar Typhimurium
• Typhi is used for the strictly human species that produce enteric (typhoid) fever.
Unless otherwise specified, S enterica is used for serotypes such as Typhimurium,
which are able to infect animals or humans and typically cause gastroenteritis.
BACTERIOLOGY
• The highest rates of infection are in children under 5 years of age, persons aged 20 to 30, and those
older than 70.
• Infecting dose is higher than Shigella
• Infections are transmitted by contaminated foods before ingestion.
• Salmonellae are a leading cause of foodborne intestinal infection.
• Poultry products (Including eggs) are common source
• Eating raw milk have been associated with outbreaks of Salmonella infection.
• Humans can also be the source of disease.
• Fully 5% of patients recovering from gastroenteritis still shed the organisms 20 weeks later.
PATHOGENESIS
• Ingested S enterica cells that pass the stomach acid and reach the small bowel.
• Initial contact with M cells, enterocytes, or both.
• Pili: for initial adherence.
• Upon engagement of S enterica injection (type III) secretion systems, formation of
membrane “ruffles” dramatically alters the normal host cell architecture within minutes
(Figure below).
• The ruffles seem to engulf the organism in an endocytotic vacuole and allow it to transcytose
from the surface to the basolateral membrane.
• Once in the cell, S enterica multiplies in a vacuole, induce a profound inflammatory response
• Then, phagocytosed by neutrophils and macrophages.
• Macrophage apoptosis aids survival
• Persisters may lead to relapse
Figure: Salmonella ruffles.
Gastroenteritis Bacteremia
• With and without focal extraintestinal infection, enteric fever, and the asymptomatic
carrier state
✺S enterica = Gastroenteritis
✺Typhi and related serotypes (Paratyphi) = Enteric fever
SALMONELLOSIS: CLINICAL ASPECTS
ØGastroenteritis
• The episode begins 24 to 48 hours after ingestion
• Nausea and vomiting followed by, abdominal cramps and diarrhea.
• Diarrhea persists, for 3 to 4 days and usually resolves spontaneously within 7 days.
• Fever (39°C) is present in about 50% of the patients.
• The spectrum of disease: from a few loose stools to a severe dysentery-like syndrome.
SALMONELLOSIS: CLINICAL ASPECTS
ØEnteric Fever
• Enteric fever is a multiorgan Salmonella infection characterized by prolonged fever, sustained bacteremia, and
profound involvement of the mesenteric lymph nodes, liver, and spleen.
• Slowly increasing fever lasts for weeks
• Diarrhea is intermittent or absent
• Endotoxin can lead to myocarditis, encephalopathy, or intravascular coagulation.
• Biliary tree infection reseeds intestine
• Urinary tract infection and metastatic lesions in bone, joint, liver, and meninges may also occur.
• The most important complication of typhoid fever is intra-abdominal hemorrhage.
DIAGNOSIS
• Culture of Salmonella from the blood or feces is the primary diagnostic method.
• Early in the course of enteric fever, blood is far more likely to give a positive culture
result.
• The media used for stool culture are the same as those used for Shigella: Failure to
ferment lactose and the production of hydrogen sulfides (H2S).
• Characteristics of biochemical tests are used to identify the genus
• O serogroup antisera are available in larger laboratories for confirmation.
TREATMENT
Ø Gastroenteritis
• The primary therapeutic approach to Salmonella gastroenteritis consists of fluid and electrolyte
replacement
• Control nausea and vomiting.
• Antimicrobials are of limited use in gastroenteritis
Ø Typhoid fever
• Chloramphenicol and then ampicillin were the first antibiotics used and reduced the mortality rate.
• Use of ampicillin is now limited by widespread resistance
• Extended- spectrum cephalosporins (ceftriaxone, cefixime) and ciprofloxacin as preferred first-line
agents.
YERSINIA
YERSINIA